FUCHS SE/ US35952Q1067 /
20/09/2024 21:27:45 | Chg. -0.2000 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
10.8850USD | -1.80% | 4,979 Turnover: 53,171.8610 |
-Bid Size: - | -Ask Size: - | 5.35 bill.USD | - | - |
GlobeNewswire
05/08
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones...
GlobeNewswire
24/07
The ADVERTISING Club of New York Taps Power Players to Join the Board of Directors; Naming Five New ...
GlobeNewswire
24/07
OTC Markets Group Announces Real-Time Data Distribution with uSMART Securities Out of Hong Kong
GlobeNewswire
04/07
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene The...
GlobeNewswire
09/05
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea E...
GlobeNewswire
08/05
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program M...
GlobeNewswire
07/05
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
02/05
insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Fin...
GlobeNewswire
10/04
BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...
GlobeNewswire
19/03
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...
GlobeNewswire
12/03
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...
GlobeNewswire
07/03
American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...
GlobeNewswire
30/01
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
24/01
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...
GlobeNewswire
09/12/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
13/11/2023
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...